Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Sigma (ASX:SIG) share price soars 36% on return to the ASX

The Sigma Healthcare Ltd (ASX:SIG) share price has jumped 36% after returning to the ASX. Chemist Warehouse is planning to list.

The Sigma Healthcare Ltd (ASX: SIG) share price has jumped 36% after returning to the ASX.

As a reminder, Sigma is in the process of ‘acquiring’ Chemist Warehouse. A lot of new Sigma shares are going to be issued to existing Chemist Warehouse shareholders who will end up owning a large majority of the business.

Why is the Sigma share price rising?

You’d have to ask each investor why they’re willing to pay so much more than a couple of weeks ago.

Sigma said the proposed merger has the potential to unlock “significant efficiencies”, with cost synergies initially estimated at around $60 million per year” which is expected to be realised four years after completion.

The combined business could have a market capitalisation of around $9 billion and it’s expected to be within the ASX 200 (ASX: XJO).

Sigma said this will create a “full-service wholesaler, distributor and retail pharmacy franchisor.” It’ll combine “extensive and state-of-the-art distribution infrastructure with Chemist Warehouse Group’s leading retailing know-how.”

The combined business will have a “larger and more diversified earnings base” with a total EBIT (EBIT explained) last financial year of more than $495 million. That means a lot more profit for the Sigma business, which could help the Sigma share price.

Sigma also pointed out the balance sheet will have greater strength as well.

Board comments

The Sigma Chairman Michael Sammells said:

The Proposed Merger is a step-change event for Sigma. With Sigma having had a commercial relationship with CWG and its founders spanning more than 40 years, we are excited by the efficiencies, synergies and growth opportunities that we anticipate being unlocked through the merger of the two complementary businesses. The combined group will have extensive capabilities and expertise to benefit franchisees and customers, including through more brand choice, products and services and expanded marketing capabilities.

Final thoughts on the Sigma share price

I can understand why investors are excited by the existing Sigma shares because the business could be much stronger, even after splitting it between a lot more shares.

It’ll be interesting to see how much of a presence Chemist Warehouse will have on the ASX if it makes it – the ACCC may decide to block the transaction.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content